Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4783104
Max Phase: Preclinical
Molecular Formula: C45H57N11O9
Molecular Weight: 896.02
Molecule Type: Unknown
Associated Items:
ID: ALA4783104
Max Phase: Preclinical
Molecular Formula: C45H57N11O9
Molecular Weight: 896.02
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CC(N)=O)C(N)=O
Standard InChI: InChI=1S/C45H57N11O9/c1-24(57)39(40(49)60)56-45(65)35(18-25-13-15-28(58)16-14-25)54-42(62)34(12-6-7-17-46)52-43(63)37(20-27-23-51-33-11-5-3-9-30(27)33)55-44(64)36(53-41(61)31(47)21-38(48)59)19-26-22-50-32-10-4-2-8-29(26)32/h2-5,8-11,13-16,22-24,31,34-37,39,50-51,57-58H,6-7,12,17-21,46-47H2,1H3,(H2,48,59)(H2,49,60)(H,52,63)(H,53,61)(H,54,62)(H,55,64)(H,56,65)/t24-,31+,34+,35+,36+,37+,39+/m1/s1
Standard InChI Key: QYXABJILOMKVOP-PMPNJECKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 896.02 | Molecular Weight (Monoisotopic): 895.4341 | AlogP: -1.00 | #Rotatable Bonds: 24 |
Polar Surface Area: 355.76 | Molecular Species: BASE | HBA: 11 | HBD: 13 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 17 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.42 | CX Basic pKa: 10.19 | CX LogP: -2.26 | CX LogD: -4.05 |
Aromatic Rings: 5 | Heavy Atoms: 65 | QED Weighted: 0.03 | Np Likeness Score: 0.22 |
1. Bandholtz S,Erdmann S,von Hacht JL,Exner S,Krause G,Kleinau G,Grötzinger C. (2016) Urolinin: The First Linear Peptidic Urotensin-II Receptor Agonist., 59 (22.0): [PMID:27791374] [10.1021/acs.jmedchem.6b00164] |
Source(1):